Literature DB >> 24280058

LGR4 and its ligands, R-spondin 1 and R-spondin 3, regulate food intake in the hypothalamus of male rats.

Ji-Yao Li1, Biaoxin Chai, Weizhen Zhang, Danielle M Fritze, Chao Zhang, Michael W Mulholland.   

Abstract

The hypothalamus plays a key role in the regulation of feeding behavior. Several hypothalamic nuclei, including the arcuate nucleus (ARC), paraventricular nucleus, and ventromedial nucleus of the hypothalamus (VMH), are involved in energy homeostasis. Analysis of microarray data derived from ARC revealed that leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) is highly expressed. LGR4, LGR5, and LGR6 form a subfamily of closely related receptors. Recently, R-spondin (Rspo) family proteins were identified as ligands of the LGR4 subfamily. In the present study, we investigated the distribution and function of LGR4-LGR6 and Rspos (1-4) in the brain of male rat. In situ hybridization showed that LGR4 is expressed in the ARC, VMH, and median eminence of the hypothalamus. LGR4 colocalizes with neuropeptide Y, proopiomelanocortin, and brain-derived neurotrophic factor neurons. LGR5 is not detectable with in situ hybridization; LGR6 is only expressed in the epithelial lining of the lower portion of the third ventricle and median eminence. Rspo1 is expressed in the VMH and down-regulated with fasting. Rspo3 is expressed in the paraventricular nucleus and also down-regulated with fasting. Rspos 1 and 3 colocalize with the neuronal marker HuD, indicating that they are expressed by neurons. Injection of Rspo1 or Rspo3 into the third brain ventricle inhibited food intake. Rspo1 decreased neuropeptide Y and increased proopiomelanocortin expression in the ARC. Rspo1 and Rspo3 mRNA is up-regulated by insulin. These data indicate that Rspo1 and Rspo3 and their receptor LGR4 form novel circuits in the brain to regulate energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24280058      PMCID: PMC3891940          DOI: 10.1210/en.2013-1550

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  Neurochemical characterization of hypothalamic cocaine- amphetamine-regulated transcript neurons.

Authors:  N Vrang; P J Larsen; J T Clausen; P Kristensen
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

2.  Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders.

Authors:  Denise D Belsham; Fang Cai; Hong Cui; Simon R Smukler; Anne Marie F Salapatek; Lulzim Shkreta
Journal:  Endocrinology       Date:  2003-10-09       Impact factor: 4.736

3.  Molecular cloning and expression of brain-derived neurotrophic factor.

Authors:  J Leibrock; F Lottspeich; A Hohn; M Hofer; B Hengerer; P Masiakowski; H Thoenen; Y A Barde
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

4.  Redefining gonadotropin-releasing hormone (GnRH) cell groups in the male Syrian hamster: testosterone regulates GnRH mRNA in the tenia tecta.

Authors:  Heather N Richardson; David B Parfitt; Robert C Thompson; Cheryl L Sisk
Journal:  J Neuroendocrinol       Date:  2002-05       Impact factor: 3.627

5.  Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension.

Authors:  Hiroki Morita; Sabine Mazerbourg; Donna M Bouley; Ching-Wei Luo; Kazuhiro Kawamura; Yoshimitsu Kuwabara; Helene Baribault; Hui Tian; Aaron J W Hsueh
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor.

Authors:  Baoji Xu; Evan H Goulding; Keling Zang; David Cepoi; Roger D Cone; Kevin R Jones; Laurence H Tecott; Louis F Reichardt
Journal:  Nat Neurosci       Date:  2003-07       Impact factor: 24.884

7.  Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality.

Authors:  Sabine Mazerbourg; Donna M Bouley; Satoko Sudo; Cynthia A Klein; Jian V Zhang; Kazuhiro Kawamura; Lisa V Goodrich; Helen Rayburn; Marc Tessier-Lavigne; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2004-06-10

8.  R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants.

Authors:  Tomoyuki Kamata; Ken-ichi Katsube; Makoto Michikawa; Masahito Yamada; Shinji Takada; Hidehiro Mizusawa
Journal:  Biochim Biophys Acta       Date:  2004-01-05

9.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

10.  Structural basis for R-spondin recognition by LGR4/5/6 receptors.

Authors:  Dongli Wang; Binlu Huang; Senyan Zhang; Xiaojuan Yu; Wei Wu; Xinquan Wang
Journal:  Genes Dev       Date:  2013-06-11       Impact factor: 11.361

View more
  10 in total

1.  LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.

Authors:  Zhiying Yue; Zengjin Yuan; Li Zeng; Ying Wang; Li Lai; Jing Li; Peng Sun; Xiwen Xue; Junyi Qi; Zhengfeng Yang; Yansen Zheng; Yuanzhang Fang; Dali Li; Stefan Siwko; Yi Li; Jian Luo; Mingyao Liu
Journal:  FASEB J       Date:  2017-12-21       Impact factor: 5.191

Review 2.  LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation.

Authors:  Joanna Filipowska; Nagesha G Kondegowda; Nancy Leon-Rivera; Sangeeta Dhawan; Rupangi C Vasavada
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

3.  Rspo1/Rspo3-LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPKα-SREBP2 pathway.

Authors:  Shiying Liu; Yuan Gao; Liping Zhang; Yue Yin; Weizhen Zhang
Journal:  FASEB J       Date:  2020-09-14       Impact factor: 5.191

Review 4.  The Role of LGR4 (GPR48) in Normal and Cancer Processes.

Authors:  Alejandro Ordaz-Ramos; Victor Hugo Rosales-Gallegos; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

5.  Notoginsenoside Fe suppresses diet induced obesity and activates paraventricular hypothalamic neurons.

Authors:  Hongli Li; Yalei Liu; Chuhe Liu; Lingling Luo; Yin Yao; Fei Li; Liufang Yin; Lai Xu; Qingchun Tong; Cheng Huang; Shengjie Fan
Journal:  RSC Adv       Date:  2019-01-11       Impact factor: 4.036

Review 6.  LGR4 and Its Role in Intestinal Protection and Energy Metabolism.

Authors:  Ziru Li; Weizhen Zhang; Michael W Mulholland
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-25       Impact factor: 5.555

7.  Silencing of R-Spondin1 increases radiosensitivity of glioma cells.

Authors:  Xuefeng Gu; Xuefeng Wang; Hong Xiao; Guoda Ma; Lili Cui; You Li; Haihong Zhou; Wandong Liang; Bin Zhao; Keshen Li
Journal:  Oncotarget       Date:  2015

8.  Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance.

Authors:  Yea Eun Kang; Ji Min Kim; Hyon Seung Yi; Kyong Hye Joung; Ju Hee Lee; Hyun Jin Kim; Bon Jeong Ku
Journal:  Diabetes Metab J       Date:  2018-10-23       Impact factor: 5.376

Review 9.  Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis.

Authors:  Linlin Yang; Jing Wang; Xiaodi Gong; Qiong Fan; Xiaoming Yang; Yunxia Cui; Xiaoyan Gao; Lijuan Li; Xiao Sun; Yuhong Li; Yudong Wang
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

10.  Association between LGR4 polymorphisms and peak bone mineral density and body composition.

Authors:  Wei-Jia Yu; Zeng Zhang; Wen-Zhen Fu; Jin-Wei He; Chun Wang; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2020-05-12       Impact factor: 2.626

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.